| Kristalyn J Mauch, MD | |
|
401 Long Rapids Plz, Alpena, MI 49707 | |
| (989) 356-9333 | |
| (989) 356-0804 |
| Full Name | Kristalyn J Mauch |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 11 Years |
| Location | 401 Long Rapids Plz, Alpena, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992048284 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midmichigan Medical Center - Alpena | Alpena, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mymichigan Medical Group | 4981501939 | 162 |
News Archive
Scientists from the Vision Cooperative Research Centre in Australia have announced that myopia, or short-sightedness, can be controlled with new technology. This ground breaking discovery was based on research conducted by Vision CRC partners – the University of Houston College of Optometry and the Brien Holden Vision Institute, located at the University of New South Wales.
The advent of therapeutic interventions for spinal muscular atrophy (SMA) has increased the importance of presymptomatic diagnosis and treatment. When to start treatment in children with less severe disease remains controversial.
A project to create a common platform throughout Europe for researchers working in the field of ‘biological crystallography' is underway thanks to a grant of 10 million euros from the EU's 6th Framework Programme (FP6).
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.
› Verified 2 days ago
| Entity Name | Mymichigan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689623506 PECOS PAC ID: 4981501939 Enrollment ID: O20060727000013 |
News Archive
Scientists from the Vision Cooperative Research Centre in Australia have announced that myopia, or short-sightedness, can be controlled with new technology. This ground breaking discovery was based on research conducted by Vision CRC partners – the University of Houston College of Optometry and the Brien Holden Vision Institute, located at the University of New South Wales.
The advent of therapeutic interventions for spinal muscular atrophy (SMA) has increased the importance of presymptomatic diagnosis and treatment. When to start treatment in children with less severe disease remains controversial.
A project to create a common platform throughout Europe for researchers working in the field of ‘biological crystallography' is underway thanks to a grant of 10 million euros from the EU's 6th Framework Programme (FP6).
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristalyn J Mauch, MD 401 Long Rapids Plz, Alpena, MI 49707-1394 Ph: (989) 356-9333 | Kristalyn J Mauch, MD 401 Long Rapids Plz, Alpena, MI 49707 Ph: (989) 356-9333 |
News Archive
Scientists from the Vision Cooperative Research Centre in Australia have announced that myopia, or short-sightedness, can be controlled with new technology. This ground breaking discovery was based on research conducted by Vision CRC partners – the University of Houston College of Optometry and the Brien Holden Vision Institute, located at the University of New South Wales.
The advent of therapeutic interventions for spinal muscular atrophy (SMA) has increased the importance of presymptomatic diagnosis and treatment. When to start treatment in children with less severe disease remains controversial.
A project to create a common platform throughout Europe for researchers working in the field of ‘biological crystallography' is underway thanks to a grant of 10 million euros from the EU's 6th Framework Programme (FP6).
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.
› Verified 2 days ago
Dr. Bruce R Ohmart, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 199 Long Rapids Road, Alpena, MI 49707 Phone: 989-356-6191 Fax: 989-354-5671 | |
Steven E Vorenkamp, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 401 Long Rapids Plz, Alpena, MI 49707 Phone: 989-356-9333 Fax: 989-356-8084 | |
Eric Robert Cornish, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 401 Long Rapids Plz, Alpena, MI 49707 Phone: 989-356-9333 Fax: 989-356-0804 | |
Dr. Kiel Thomas Beltinck, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 401 Long Rapids Plz, Alpena, MI 49707 Phone: 989-356-9333 |